Wednesday, October 09, 2024 9:31:21 PM
Full of BS, as usual!
You know that no big pharma is going to partner with NWBO and therefore you do not want to place a bet that you know you will lose. I will give you until end of June 2025. The deal is big pharma PRs a partnership deal (it can be combo trial partnership or literally anything) and injects cash by end of June 2025. Cash injection can be any amount. Deal?
Stop with your BS that Flaskworks is needed for regulatory applications or running combo trials. Its not. LP herself said at the ASM that Flaskworks is not needed. She knows she will get sued if she lied along these lines. Thats why folks like you are deployed to toe that line on social media and shield the management for their non performance (to shareholders). They can apply to any regulatory agency with manual method and also run a combo trial with manual method just as they did with phase 3 GBM and the ph 1/2 trials at UCLA. No point wasting time.
I also gave you an opportunity to place a bet about your white knight scenario which you refused. Again, that bet is the white knight invests $50M or more at greater than $2B market cap valuation by end of March 2025. You say yes and I say no. Deal?
No big pharma is interested. No one will blink. However, LP is desperate as she has been selling cheapies at 30 cents. You can’t even back her leverage/negotiations skills at UK approval with the upcoming white knight raise.
You know that no big pharma is going to partner with NWBO and therefore you do not want to place a bet that you know you will lose. I will give you until end of June 2025. The deal is big pharma PRs a partnership deal (it can be combo trial partnership or literally anything) and injects cash by end of June 2025. Cash injection can be any amount. Deal?
Stop with your BS that Flaskworks is needed for regulatory applications or running combo trials. Its not. LP herself said at the ASM that Flaskworks is not needed. She knows she will get sued if she lied along these lines. Thats why folks like you are deployed to toe that line on social media and shield the management for their non performance (to shareholders). They can apply to any regulatory agency with manual method and also run a combo trial with manual method just as they did with phase 3 GBM and the ph 1/2 trials at UCLA. No point wasting time.
I also gave you an opportunity to place a bet about your white knight scenario which you refused. Again, that bet is the white knight invests $50M or more at greater than $2B market cap valuation by end of March 2025. You say yes and I say no. Deal?
No big pharma is interested. No one will blink. However, LP is desperate as she has been selling cheapies at 30 cents. You can’t even back her leverage/negotiations skills at UK approval with the upcoming white knight raise.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
